| Interleukin-18 binding protein deficiency results in gut microbiota dysbiosis and aggravated diet-induced MASH in mice | JHEP reports | | | 2026 | 48 | 61 |
|
| Interleukin‐18 Binding Protein (IL‐18BP) Deficiency Affects Lymphocyte Activation and IL‐18 Expression in a Mouse Model of Liver Inflammation | European Journal of Immunology | | | 2025 | 115 | 367 |
|
| Interleukin-18 binding protein protects against metabolic steatohepatitis | Hepatology communications | | | 2025 | 9 | 17 |
|
| Alerte au feu : des nanopompiers pour combattre les flammes de la polyarthrite rhumatoïde | Revue médicale suisse | | | 2024 | 211 | 33 |
|
| Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox inrheumatoid arthritis | ESC (Europan Society of Cardiology) Congress 2024 | | | 2024 | 13 | 0 |
|
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis | 92nd EAS (European Atherosclerosis Society) Congress | | | 2024 | 22 | 0 |
|
| Rhumatologie en crise : repenser la formation et les soins face à un défi croissant | Revue médicale suisse | | | 2024 | 46 | 135 |
|
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis | Frontiers in cardiovascular medicine | | | 2024 | 128 | 284 |
|
| Prospective registration of trials : where we are, why, and how we could get better | Journal of clinical epidemiology | | | 2024 | 64 | 395 |
|
| Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies | Joint bone spine | | | 2024 | 112 | 164 |
|
| IL-18 Binding Protein–Producing Cells Attenuate Anemia in Murine Macrophage Activation Syndrome | The Journal of immunology | | | 2023 | 130 | 362 |
|
| Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases | Frontiers in immunology | | | 2023 | 139 | 107 |
|
| Reporting and Representativeness of Race, Ethnicity, and Socioeconomic Status in Systemic Sclerosis Randomized Trials: An Observational Study | Arthritis care & research | | | 2023 | 78 | 358 |
|
| Special Issue “IL-1 family cytokines in host defense, inflammation and cancer” | Cytokine | | | 2022 | 216 | 310 |
|
| Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controls | Vaccine | | | 2022 | 78 | 0 |
|
| Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling | Arthritis & rheumatology | | | 2022 | 141 | 179 |
|
| Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints | Cytokine | | | 2022 | 210 | 862 |
|
| Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis | Rheumatology | | | 2021 | 386 | 582 |
|
| The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries | Rheumatology | | | 2021 | 256 | 0 |
|
| Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes using disease-related blood biomarkers | Arthritis and Rheumatology | | | 2021 | 205 | 321 |
|
| Intracellular IL-1 receptor antagonist isoform 1 released from keratinocytes upon cell death acts as an inhibitor for the alarmin IL-1α | Journal of Immunology | | | 2020 | 373 | 2 |
|
| Response to: 'When binary and continuous responses disagree' by Dr Ouyang | Annals of the Rheumatic Diseases | | | 2020 | 330 | 2 |
|
| Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools | Clinical and Experimental Rheumatology | | | 2020 | 293 | 197 |
|
| Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis | Arthritis Research and Therapy | | | 2020 | 422 | 623 |
|
| IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis | Life Science Alliance | | | 2020 | 224 | 447 |
|
| Individual therapeutic DAS28-d crit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies | Rheumatology International | | | 2020 | 259 | 170 |
|
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | | | 2020 | 346 | 674 |
|
| Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities | RMD Open | | | 2020 | 148 | 78 |
|
| IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome | Rheumatology | | | 2020 | 284 | 0 |
|
| Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial | The Lancet | | | 2020 | 315 | 0 |
|
| The role of the IL-1 system in pregnancy and the use of IL-1 system markers to identify women at risk for pregnancy complications† | Biology of Reproduction | | | 2020 | 171 | 0 |
|
| IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome | Rheumatology | | | 2020 | 345 | 1 |
|
| Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome | Journal of Immunology | | | 2020 | 293 | 1 |
|
| Randomized clinical trials in ANCA-associated vasculitis: a systematic analysis of the WHO - International Clinical Trials Registry Platform | Orphanet Journal of Rare Diseases | | | 2020 | 173 | 204 |
|
| Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes | Arthritis Research and Therapy | | | 2020 | 203 | 171 |
|
| Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland | RMD Open | | | 2020 | 228 | 146 |
|
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | | | 2020 | 339 | 9 |
|
| Travel patterns, risk behaviour and health problems of travellers with rheumatic diseases compared to controls: A multi-centre, observational study | Travel Medicine and Infectious Disease | | | 2020 | 177 | 0 |
|
| Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab | Advances in Rheumatology | | | 2019 | 307 | 156 |
|
| Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution | Rheumatology | | | 2019 | 382 | 0 |
|
| Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study | Rheumatology | | | 2019 | 317 | 0 |
|
| The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis | British Journal of Haematology | | | 2019 | 266 | 0 |
|
| Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort | Rheumatology | | | 2019 | 278 | 0 |
|
| Long-term therapy with anakinra in hidradenitis suppurativa in three patients | International Journal of Dermatology | | | 2019 | 339 | 1 |
|
| Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions | Seminars in Arthritis and Rheumatism | | | 2019 | 289 | 0 |
|
| Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis | RMD Open | | | 2019 | 347 | 163 |
|
| Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis | Seminars in Arthritis and Rheumatism | | | 2019 | 329 | 264 |
|
| Prevotella copri in individuals at risk for rheumatoid arthritis | Annals of the Rheumatic Diseases | | | 2019 | 476 | 0 |
|
| Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection | European Journal of Immunology | | | 2018 | 413 | 0 |
|
| Biological agents in the management of adult-onset Still's disease | Joint, Bone, Spine | | | 2018 | 425 | 439 |
|
| Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration | Annals of the Rheumatic Diseases | | | 2018 | 468 | 1 |
|
| Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism | Cancer Research | | | 2018 | 425 | 0 |
|
| Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries | RMD Open | | | 2018 | 363 | 199 |
|
| Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice | Blood | | | 2018 | 472 | 2 |
|
| Regulation and function of interleukin-36 cytokines | Immunological Reviews | | | 2018 | 482 | 0 |
|
| Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study | RMD Open | | | 2018 | 443 | 251 |
|
| β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion | Cell Reports | | | 2018 | 616 | 348 |
|
| Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome | Blood | | | 2018 | 383 | 1 |
|
| Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease | Annals of the Rheumatic Diseases | | | 2018 | 547 | 432 |
|
| Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance | Frontiers in Immunology | | | 2018 | 439 | 393 |
|
| Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis | Arthritis Care and Research | | | 2018 | 448 | 546 |
|
| Nanocrystal-Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment | Small | | | 2018 | 653 | 471 |
|
| The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis | Swiss Medical Weekly | | | 2017 | 592 | 505 |
|
| Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis | Rheumatology | | | 2017 | 566 | 5 |
|
| The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis | Clinical Rheumatology | | | 2017 | 640 | 3 |
|
| Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition | Journal of Allergy and Clinical Immunology | | | 2017 | 452 | 2 |
|
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update | Annals of the Rheumatic Diseases | | | 2017 | 491 | 2 |
|
| International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus | Autoimmunity Reviews | | | 2017 | 418 | 1 |
|
| Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials | RMD Open | | | 2017 | 399 | 261 |
|
| Cardiovascular risk in patients with rheumatoid arthritis | Seminars in Immunopathology | | | 2017 | 469 | 0 |
|
| Rheumatoid arthritis: from basic findings and clinical manifestations to future therapies | Seminars in Immunopathology | | | 2017 | 371 | 0 |
|
| Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis | Arthritis and Rheumatology | | | 2017 | 556 | 0 |
|
| Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration | Journal of Rheumatology | | | 2017 | 443 | 1 |
|
| Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis | PLOS ONE | | | 2017 | 570 | 281 |
|
| Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype | PloS one | | | 2017 | 573 | 519 |
|
| IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro | Annals of the Rheumatic Diseases | | | 2017 | 444 | 0 |
|
| Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab | RMD Open | | | 2017 | 402 | 379 |
|
| The role of female hormonal factors in the development of rheumatoid arthritis | Rheumatology | | | 2017 | 478 | 0 |
|
| Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses | Journal of Immunology | | | 2017 | 770 | 2 |
|
| The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis | Arthritis & rheumatology | | | 2016 | 541 | 0 |
|
| A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease | Arthritis Research and Therapy | | | 2016 | 1,074 | 374 |
|
| Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease | Clinical and experimental immunology | | | 2016 | 557 | 2 |
|
| Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis | Annals of the rheumatic diseases | | | 2016 | 572 | 274 |
|
| Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines | Cytokine | | | 2016 | 538 | 1 |
|
| Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study | Annals of the rheumatic diseases | | | 2016 | 539 | 0 |
|
| Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis | Rheumatology | | | 2016 | 537 | 0 |
|
| IL-1R1-MyD88 axis elicits papain-induced lung inflammation | European Journal of Immunology | | | 2016 | 582 | 0 |
|
| IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells | Journal of Immunology | | | 2016 | 562 | 2 |
|
| Elevated serum levels of free interleukin-18 in adult-onset Still's disease | Rheumatology | | | 2016 | 570 | 0 |
|
| SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype | Journal of leukocyte biology | | | 2016 | 524 | 1 |
|
| Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration | Arthritis Research and Therapy | | | 2016 | 507 | 255 |
|
| Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice | International journal of pharmaceutics | | | 2016 | 891 | 4 |
|
| The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases | Cytokine | | | 2015 | 338 | 0 |
|
| Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection | PloS one | | | 2015 | 572 | 334 |
|
| Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry | Rheumatology | | | 2015 | 510 | 0 |
|
| Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling | Immunity, inflammation and disease | | | 2015 | 1,206 | 239 |
|
| The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists | Dermatology | | | 2015 | 474 | 0 |
|
| Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 Mice | The Journal of immunology | | | 2015 | 690 | 2 |
|
| Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal study | Arthritis research & therapy | | | 2015 | 557 | 634 |
|
| Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study | Inflammatory bowel diseases | | | 2015 | 506 | 0 |
|
| Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system | European journal of pharmaceutics and biopharmaceutics | | | 2015 | 691 | 4 |
|
| Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics | Arthritis research & therapy | | | 2014 | 581 | 638 |
|
| Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | | | 2014 | 686 | 0 |
|
| Inflammation: IL-36 has proinflammatory effects in skin but not in joints | Nature reviews. Rheumatology | | | 2014 | 594 | 0 |
|
| Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee | International orthopaedics | | | 2014 | 593 | 0 |
|
| Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? | Journal of rheumatology | | | 2014 | 537 | 0 |
|
| Traitement de fond de la polyarthrite rhumatoïde | Revue médicale suisse | | | 2014 | 303 | 2 |
|
| Biological agents in monotherapy for the treatment of rheumatoid arthritis | Schweizerische medizinische Wochenschrift | | | 2014 | 615 | 2 |
|
| In Black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides α36-50Cit38,42 and β60-74Cit60,72,74, like in Caucasians | Clinical immunology | | | 2014 | 636 | 1 |
|
| Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour | Annals of the rheumatic diseases | | | 2014 | 685 | 2 |
|
| Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout | Arthritis & rheumatology | | | 2014 | 727 | 0 |
|
| The severity of experimental arthritis is independent of IL-36 receptor signaling | Arthritis research & therapy | | | 2013 | 642 | 388 |
|
| Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions | Journal of leukocyte biology | | | 2013 | 559 | 603 |
|
| Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis" | Joint bone spine | | | 2013 | 584 | 0 |
|
| Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement | Annals of the rheumatic diseases | | | 2013 | 714 | 568 |
|
| Hand osteoarthritis: new insights | Joint bone spine | | | 2013 | 661 | 0 |
|
| Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions | Annals of the rheumatic diseases | | | 2013 | 628 | 428 |
|
| Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply | Lancet | | | 2013 | 540 | 0 |
|
| Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency | Arthritis research & therapy | | | 2013 | 657 | 315 |
|
| Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience | Schweizerische medizinische Wochenschrift | | | 2013 | 847 | 517 |
|
| Do synovial leptin levels correlate with pain in end stage arthritis? | International orthopaedics | | | 2013 | 688 | 283 |
|
| Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial | Lancet | | | 2013 | 665 | 0 |
|
| The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans | Frontiers in immunology | | | 2013 | 608 | 459 |
|
| Endogenous IL-1α is a chromatin-associated protein in mouse macrophages | Cytokine | | | 2013 | 652 | 1 |
|
| Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome | Joint bone spine | | | 2013 | 651 | 0 |
|
| Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial | Annals of the rheumatic diseases | | | 2012 | 686 | 0 |
|
| Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments | Arthritis and rheumatism | | | 2012 | 636 | 1 |
|
| Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists | Annals of the rheumatic diseases | | | 2012 | 577 | 449 |
|
| Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis | Joint bone spine | | | 2012 | 763 | 919 |
|
| Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? | Arthritis care & research | | | 2012 | 709 | 0 |
|
| Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis | European Journal of Immunology | | | 2012 | 635 | 3 |
|
| The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | Journal of leukocyte biology | | | 2012 | 724 | 0 |
|
| Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease | Arthritis research & therapy | | | 2012 | 727 | 412 |
|
| IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells | Blood | | | 2012 | 895 | 1,108 |
|
| Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration | Annals of the rheumatic diseases | | | 2012 | 627 | 1 |
|
| EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis | Annals of the rheumatic diseases | | | 2012 | 712 | 598 |
|
| Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients | Annals of the rheumatic diseases | | | 2012 | 691 | 0 |
|
| Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice | Annals of the rheumatic diseases | | | 2012 | 690 | 0 |
|
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | | | 2011 | 1,064 | 693 |
|
| Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries | Annals of the rheumatic diseases | | | 2011 | 565 | 0 |
|
| IL-36R ligands are potent regulators of dendritic and T cells | Blood | | | 2011 | 671 | 0 |
|
| Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection | Microbes and infection | | | 2011 | 627 | 0 |
|
| Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center | Arthritis and rheumatism | | | 2011 | 699 | 0 |
|
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | | | 2011 | 892 | 8 |
|
| IL-33 biology with potential insights into human diseases | Nature reviews. Rheumatology | | | 2011 | 622 | 0 |
|
| Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions | Rheumatology | | | 2011 | 688 | 1 |
|
| The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study | Rheumatology | | | 2011 | 620 | 0 |
|
| Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis | Arthritis and rheumatism | | | 2011 | 659 | 0 |
|
| Polyarthrite rhumatoïde,méthotrexate et fibrose pulmonaire : quelles évidences ? | Revue médicale suisse | | | 2010 | 861 | 1 |
|
| Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins | BMC immunology | | | 2010 | 612 | 515 |
|
| Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice | The Journal of immunology | | | 2010 | 577 | 0 |
|
| Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists | Joint bone spine | | | 2010 | 728 | 0 |
|
| Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist | Arthritis and rheumatism | | | 2010 | 632 | 0 |
|
| Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients | Joint bone spine | | | 2010 | 629 | 0 |
|
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the rheumatic diseases | | | 2010 | 690 | 0 |
|
| Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients | Arthritis research & therapy | | | 2010 | 804 | 605 |
|
| Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis | Arthritis and rheumatism | | | 2010 | 922 | 3 |
|
| IL-1 pathways in inflammation and human diseases | Nature reviews. Rheumatology | | | 2010 | 757 | 1 |
|
| The effect of alcohol on radiographic progression in rheumatoid arthritis | Arthritis and rheumatism | | | 2010 | 609 | 0 |
|
| Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? | Annals of the rheumatic diseases | | | 2010 | 610 | 0 |
|
| Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial | Arthritis and rheumatism | | | 2010 | 686 | 0 |
|
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | | | 2009 | 670 | 0 |
|
| Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies | Schweizerische medizinische Wochenschrift | | | 2009 | 645 | 499 |
|
| Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaounde-Cameroon | Clinical rheumatology | | | 2009 | 615 | 0 |
|
| Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice | Arthritis research & therapy | | | 2009 | 815 | 850 |
|
| Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis | Arthritis and rheumatism | | | 2009 | 645 | 0 |
|
| Mutations in the IL1RN locus lead to autoinflammation | Nature reviews. Rheumatology | | | 2009 | 595 | 0 |
|
| Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritis | Clinical and Experimental Rheumatology | | | 2009 | 596 | 0 |
|
| Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure | Joint bone spine | | | 2009 | 585 | 0 |
|
| The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases | Arthritis research & therapy | | | 2009 | 620 | 232 |
|
| Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memory | The Journal of immunology | | | 2009 | 884 | 0 |
|
| The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study | Annals of the rheumatic diseases | | | 2009 | 625 | 0 |
|
| Interleukin-33 is biologically active independently of caspase-1 cleavage | The Journal of biological chemistry | | | 2009 | 696 | 573 |
|
| Synovial tissues concentrate secreted APRIL | Arthritis research & therapy | | | 2009 | 678 | 400 |
|
| The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14 | The Journal of immunology | | | 2008 | 644 | 0 |
|
| Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis? | Nature reviews. Rheumatology | | | 2008 | 610 | 0 |
|
| IL-1, IL-18, and IL-33 families of cytokines | Immunological reviews | | | 2008 | 928 | 4,153 |
|
| Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc | Spine | | | 2008 | 690 | 0 |
|
| Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease | Scandinavian journal of gastroenterology | | | 2008 | 659 | 0 |
|
| The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 | Cytokine | | | 2008 | 724 | 0 |
|
| At the horizon of innovative therapy in rheumatology: new biologic agents | Current opinion in rheumatology | | | 2008 | 640 | 0 |
|
| Molecular Characterization and Subcellular Localization of Macrophage Infectivity Potentiator, a Chlamydia trachomatis Lipoprotein | Journal of Bacteriology | | | 2007 | 790 | 751 |
|
| Expression and function of junctional adhesion molecule-C in human and experimental arthritis | Arthritis research & therapy | | | 2007 | 662 | 357 |
|
| Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells | Cytokine | | | 2007 | 535 | 0 |
|
| B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents | Arthritis and rheumatism | | | 2007 | 187 | 1 |
|
| Leukocyte migration to rheumatoid joints: Enzymes take over | Arthritis and rheumatism | | | 2006 | 612 | 1 |
|
| Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis | Clinical and Experimental Rheumatology | | | 2006 | 555 | 0 |
|
| The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes | Arthritis research & therapy | | | 2006 | 599 | 405 |
|
| Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility | Cytokine | | | 2005 | 551 | 531 |
|
| Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice | Arthritis research & therapy | | | 2004 | 500 | 203 |
|
| Total hip prosthetic joint infection due to Veillonella species | Joint bone spine | | | 2004 | 652 | 0 |
|
